DK1545548T3 - Anvendelsen af kombinationen af ciclesonid og antihistaminer til behandingen af allergisk rhinitis - Google Patents

Anvendelsen af kombinationen af ciclesonid og antihistaminer til behandingen af allergisk rhinitis

Info

Publication number: DK1545548T3
Authority: DK; Denmark
Prior art keywords: ciclesonide; antihistamines; combination; treatment; allergic rhinitis
Prior art date: 2002-08-30

Application number

DK03755551.3T

Other languages

English (en)

Inventor

Degenhard Marx

Helgert Mueller

Original Assignee

Nycomed Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-08-30

Filing date

2003-08-29

Publication date

2010-09-27

2003-08-29 Application filed by Nycomed Gmbh filed Critical Nycomed Gmbh

2010-09-27 Application granted granted Critical

2010-09-27 Publication of DK1545548T3 publication Critical patent/DK1545548T3/da

Links

LUKZNWIVRBCLON-GXOBDPJESA-N Ciclesonide Chemical compound C1([C@H]2O[C@@]3([C@H](O2)C[C@@H]2[C@@]3(C[C@H](O)[C@@H]3[C@@]4(C)C=CC(=O)C=C4CC[C@H]32)C)C(=O)COC(=O)C(C)C)CCCCC1 LUKZNWIVRBCLON-GXOBDPJESA-N 0.000 title abstract 2
229940125715 antihistaminic agent Drugs 0.000 title abstract 2
239000000739 antihistaminic agent Substances 0.000 title abstract 2
229960003728 ciclesonide Drugs 0.000 title abstract 2
206010039085 Rhinitis allergic Diseases 0.000 title 1
201000010105 allergic rhinitis Diseases 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Pulmonology (AREA)
Otolaryngology (AREA)
Ophthalmology & Optometry (AREA)
Immunology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

DK03755551.3T 2002-08-30 2003-08-29 Anvendelsen af kombinationen af ciclesonid og antihistaminer til behandingen af allergisk rhinitis DK1545548T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP02019406		2002-08-30
PCT/EP2003/009622 WO2004019955A1 (en)	2002-08-30	2003-08-29	The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis

Publications (1)

Publication Number	Publication Date
DK1545548T3 true DK1545548T3 (da)	2010-09-27

Family

ID=31970274

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK03755551.3T DK1545548T3 (da)	2002-08-30	2003-08-29	Anvendelsen af kombinationen af ciclesonid og antihistaminer til behandingen af allergisk rhinitis

Country Status (21)

Country	Link
US (2)	US7879832B2 (da)
EP (2)	EP1545548B1 (da)
JP (2)	JP4746318B2 (da)
KR (1)	KR101067795B1 (da)
CN (1)	CN1674916A (da)
AT (1)	ATE472329T1 (da)
AU (1)	AU2003273396B2 (da)
BR (2)	BR0313611A (da)
CA (1)	CA2495830C (da)
DE (1)	DE60333205D1 (da)
DK (1)	DK1545548T3 (da)
ES (2)	ES2348034T3 (da)
IL (1)	IL166483A (da)
MX (1)	MXPA05001885A (da)
NO (1)	NO335400B1 (da)
NZ (1)	NZ538954A (da)
PL (1)	PL373433A1 (da)
PT (1)	PT1545548E (da)
SI (1)	SI1545548T1 (da)
WO (1)	WO2004019955A1 (da)
ZA (1)	ZA200500719B (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2389530B (en)	2002-06-14	2007-01-10	Cipla Ltd	Pharmaceutical compositions
PT1572217E (pt) *	2002-12-12	2008-11-28	Nycomed Gmbh	Medicamento combinado de r,r-formoterol e ciclesonida
EP1635845A1 (en) *	2003-06-13	2006-03-22	ALTANA Pharma AG	Formoterol and ciclesonide combination
PE20050941A1 (es) *	2003-12-16	2005-11-08	Nycomed Gmbh	Suspensiones acuosas de ciclesonida para nebulizacion
US20070020330A1 (en)	2004-11-24	2007-01-25	Medpointe Healthcare Inc.	Compositions comprising azelastine and methods of use thereof
DK2486942T3 (da)	2004-11-24	2019-01-28	Meda Pharmaceuticals Inc	Sammensætninger, der omfatter azelastin og fremgangsmåder til anvendelse deraf
US8758816B2 (en)	2004-11-24	2014-06-24	Meda Pharmaceuticals Inc.	Compositions comprising azelastine and methods of use thereof
WO2006097458A1 (en) *	2005-03-15	2006-09-21	Nycomed Gmbh	Novel combination
US20080311196A1 (en) *	2006-07-13	2008-12-18	White Donna F	All Day Rhinitic Condition Treatment Regimen
US20080015241A1 (en) *	2006-07-13	2008-01-17	Cornerstone Biopharma, Inc.	All day rhinitic condition treatment regimen
JP5661985B2 (ja) *	2006-12-27	2015-01-28	帝人ファーマ株式会社	無菌性水性懸濁製剤
KR100878698B1 (ko) *	2007-04-05	2009-01-13	한미약품 주식회사	결정형의 베포타스틴 금속염 수화물, 이의 제조방법 및이를 포함하는 약학 조성물
KR20130099140A (ko) *	2010-10-06	2013-09-05	이스타 파머슈티컬즈, 인크.	베포타스틴 조성물
WO2012094283A2 (en) *	2011-01-04	2012-07-12	Ista Pharmaceuticals, Inc.	Bepotastine compositions
CN105307655B (zh)	2013-03-13	2019-05-03	弗拉特利发现实验室有限责任公司	哒嗪酮化合物及其用于制备治疗囊肿状纤维化的药物的应用
CN106692115A (zh) *	2015-11-13	2017-05-24	天津金耀集团有限公司	一种环索奈德混悬鼻喷剂组合物

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL132137C (da)	1963-04-24
US3813384A (en) *	1972-01-17	1974-05-28	Asta Werke Ag Chem Fab	Basically substituted benzyl phthalazone derivatives,acid salts thereof and process for the production thereof
US4369184A (en)	1980-01-24	1983-01-18	Janssen Pharmaceutica N.V.	1-(Cyclohexyl)-4-aryl-4-piperidinecarboxylic acid derivatives
JPS6150978A (ja)	1984-08-16	1986-03-13	Takeda Chem Ind Ltd	ピリジン誘導体およびその製造法
ES2053678T3 (es) *	1987-11-13	1994-08-01	Asta Medica Ag	Procedimiento para preparar un medicamento con contenido de azelastina para la aplicacion nasal y/u ocular.
GR1001529B (el)	1990-09-07	1994-03-31	Elmuquimica Farm Sl	Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης.
ATE172739T1 (de)	1993-04-02	1998-11-15	Byk Gulden Lomberg Chem Fab	Neue prednisolonderivate
EP0709099A3 (en)	1994-09-28	1996-07-24	Senju Pharma Co	Aqueous suspension for nasal administration containing cyclodextrin
DE19541689A1 (de)	1994-11-14	1996-05-15	Byk Gulden Lomberg Chem Fab	Kombinationsarzneimittel
WO1997001337A1 (en)	1995-06-29	1997-01-16	Mcneil-Ppc, Inc.	The combination of topical nasal antihistamines and topical nasal steroids
WO1997001341A1 (en)	1995-06-29	1997-01-16	Mcneil-Ppc, Inc.	The combination of topical nasal mast cell stabilizers and topical nasal steroids
EP0780127A1 (en)	1995-12-19	1997-06-25	The Procter & Gamble Company	A nasal spray containing a steroid and a antihistamine
JPH11511758A (ja)	1996-06-04	1999-10-12	ザ、プロクター、エンド、ギャンブル、カンパニー	鼻腔用ステロイドと抗ヒスタミン剤を含む鼻腔内噴霧薬
FR2754712B1 (fr) *	1996-10-17	1999-09-03	Merck Sharp Dohme Chibret Lab	Compositions ophtalmiques
US20020111495A1 (en) *	1997-04-04	2002-08-15	Pfizer Inc.	Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes
CA2281789A1 (en)	1997-04-30	1998-11-05	Warner-Lambert Company	Topical nasal antiinflammatory compositions
EP0903151A1 (en) *	1997-09-22	1999-03-24	ASTA Medica Aktiengesellschaft	Use of combinations comprising non-sedating antihistamines and alpha-adrenergic drugs for the topical treatment of rhinitis/conjunctivitis and cold, cold-like and/or flu symptoms
TWI243687B (en) *	1998-04-21	2005-11-21	Teijin Ltd	Pharmaceutical composition for application to mucosa
US6297227B1 (en) *	1998-09-10	2001-10-02	Schering Corporation	Methods and compositions for treating sinusitis, otitis media and other related disorders using antihistamines
US20020061281A1 (en) *	1999-07-06	2002-05-23	Osbakken Robert S.	Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
DE19947234A1 (de) *	1999-09-30	2001-04-05	Asta Medica Ag	Neue Kombination von Loteprednol und Antihistaminika
EP1142565A4 (en)	1999-10-20	2004-03-17	Teijin Ltd	AQUEOUS THERAPEUTIC COMPOSITIONS
AR026072A1 (es) *	1999-10-20	2002-12-26	Nycomed Gmbh	Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa
AR026073A1 (es)	1999-10-20	2002-12-26	Nycomed Gmbh	Composicion farmaceutica acuosa que contiene ciclesonida
US6649602B1 (en)	1999-11-18	2003-11-18	Alcon, Inc.	Use of an H1 antagonist and a safe steroid to treat eye conditions
US20040097486A1 (en) *	1999-11-18	2004-05-20	Yanni John M.	Use of an H1 antagonist and a safe steroid to treat eye conditions
US6653313B2 (en)	2000-08-10	2003-11-25	Warner-Lambert Company Llc	1,4-dihydropyridine compounds as bradykinin antagonists
US6706726B2 (en) *	2000-10-14	2004-03-16	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Anticholinergics which may be used as medicaments as well as processes for preparing them
ES2258175T3 (es)	2001-12-05	2006-08-16	Alcon, Inc.	Utilizacion de un antagonista de h1 y remixolona como esteroide inofensivo para el tratamiento de la rinitis.
GB2389530B (en) *	2002-06-14	2007-01-10	Cipla Ltd	Pharmaceutical compositions
BR0316203A (pt) *	2002-11-12	2005-10-04	Alcon Inc	Uso de um agente antialérgico e um esteróide para tratar rinite alérgica

2003
- 2003-08-29 PL PL03373433A patent/PL373433A1/xx not_active Application Discontinuation
- 2003-08-29 KR KR1020057002903A patent/KR101067795B1/ko not_active Expired - Lifetime
- 2003-08-29 SI SI200331870T patent/SI1545548T1/sl unknown
- 2003-08-29 BR BR0313611-6A patent/BR0313611A/pt not_active IP Right Cessation
- 2003-08-29 AU AU2003273396A patent/AU2003273396B2/en not_active Expired
- 2003-08-29 CA CA2495830A patent/CA2495830C/en not_active Expired - Fee Related
- 2003-08-29 EP EP03755551A patent/EP1545548B1/en not_active Expired - Lifetime
- 2003-08-29 ES ES03755551T patent/ES2348034T3/es not_active Expired - Lifetime
- 2003-08-29 JP JP2004532150A patent/JP4746318B2/ja not_active Expired - Lifetime
- 2003-08-29 DK DK03755551.3T patent/DK1545548T3/da active
- 2003-08-29 MX MXPA05001885A patent/MXPA05001885A/es active IP Right Grant
- 2003-08-29 DE DE60333205T patent/DE60333205D1/de not_active Expired - Lifetime
- 2003-08-29 ES ES10167527T patent/ES2393864T3/es not_active Expired - Lifetime
- 2003-08-29 PT PT03755551T patent/PT1545548E/pt unknown
- 2003-08-29 BR BRPI0313611-6A patent/BRPI0313611B1/pt unknown
- 2003-08-29 CN CNA038198606A patent/CN1674916A/zh active Pending
- 2003-08-29 NZ NZ538954A patent/NZ538954A/en not_active IP Right Cessation
- 2003-08-29 EP EP10167527A patent/EP2295062B1/en not_active Expired - Lifetime
- 2003-08-29 US US10/524,821 patent/US7879832B2/en not_active Expired - Lifetime
- 2003-08-29 AT AT03755551T patent/ATE472329T1/de active
- 2003-08-29 WO PCT/EP2003/009622 patent/WO2004019955A1/en not_active Ceased
2005
- 2005-01-25 ZA ZA200500719A patent/ZA200500719B/xx unknown
- 2005-01-25 IL IL166483A patent/IL166483A/en active IP Right Grant
- 2005-03-22 NO NO20051521A patent/NO335400B1/no not_active IP Right Cessation
2010
- 2010-11-05 JP JP2010248760A patent/JP2011021043A/ja active Pending
- 2010-12-20 US US12/973,414 patent/US8486923B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
ATE472329T1 (de)	2010-07-15
EP2295062B1 (en)	2012-08-29
NO20051521D0 (no)	2005-03-22
CN1674916A (zh)	2005-09-28
KR20050058400A (ko)	2005-06-16
WO2004019955A1 (en)	2004-03-11
DE60333205D1 (de)	2010-08-12
PT1545548E (pt)	2010-09-02
EP1545548B1 (en)	2010-06-30
KR101067795B1 (ko)	2011-09-27
JP2005539044A (ja)	2005-12-22
US20110092471A1 (en)	2011-04-21
JP2011021043A (ja)	2011-02-03
BRPI0313611B1 (pt)	2018-03-06
EP1545548A1 (en)	2005-06-29
BR0313611A (pt)	2005-06-21
CA2495830C (en)	2012-08-21
NO20051521L (no)	2005-03-22
AU2003273396A1 (en)	2004-03-19
PL373433A1 (en)	2005-08-22
NZ538954A (en)	2007-04-27
SI1545548T1 (sl)	2010-11-30
US7879832B2 (en)	2011-02-01
EP2295062A1 (en)	2011-03-16
IL166483A (en)	2013-11-28
CA2495830A1 (en)	2004-03-11
US8486923B2 (en)	2013-07-16
MXPA05001885A (es)	2005-06-03
ES2393864T3 (es)	2012-12-28
IL166483A0 (en)	2006-01-15
US20050245493A1 (en)	2005-11-03
JP4746318B2 (ja)	2011-08-10
ZA200500719B (en)	2006-02-22
ES2348034T3 (es)	2010-11-29
AU2003273396B2 (en)	2008-12-11
NO335400B1 (no)	2014-12-08

Publication	Publication Date	Title
DK1423381T3 (da)	2007-05-07	17beta-hydroxysteroid-dehydrogenase type 3-inhibitorer til behandling af androgenafhængige sygdomme
DK1660057T3 (da)	2012-08-20	Kombinationsterapi til behandling af neovaskulære øjenlidelser
DK1663978T3 (da)	2008-04-07	Fluorsubstitueret omega-carboxyaryl-diphenylurinstof til behandling og forebyggelse af sygdomme og lidelser
NO20051521L (no)	2005-03-22	Anvendelse av kombinasjonen av ciclesonid og antihistaminer for behandlingen av allergisk rhinitt
DK2298338T3 (da)	2012-09-24	Lactoferrin-sammensætninger og fremgangsmåder til behandling af hudsår
DK2700309T3 (da)	2019-09-16	Sammensætninger omfattende et kollagenbiovæv til anvendelse ved behandling af sygdomme og lidelser
DK1673104T3 (da)	2014-01-20	Fremføring af terapeutiske forbindelser til hjernen og andre væv
DK1944322T3 (da)	2015-06-22	Behandling af TNFalfa-relaterede sygdomme
DE60322582D1 (de)	2008-09-11	Oberflächenbehandlung von medizinischem gerät
DK1773999T3 (da)	2010-01-18	Vaccine til forebyggelse og behandling af HIV-infektion
DK1644021T3 (da)	2012-10-29	Fremgangsmåder og sammensætninger til behandlingen af gastrointestinale sygdomme
DE60231295D1 (de)	2009-04-09	R und ppar modulatoren
DK1814590T4 (da)	2014-02-24	Behandling af obesitet og beslægtede sygdomme.
DE60237725D1 (de)	2010-10-28	Vervendung von dexrazoxane in der prävention und behandlung der alzeheimer-krankheit
DE60229922D1 (de)	2009-01-02	Kombinationen, ein antidiarrhoikum und epothilon oder ein epothilonderivat enthaltend
DK1392292T3 (da)	2006-05-29	Pyranoindazoler og deres anvendelse til behandling af glaukom
PT2322546E (pt)	2016-01-22	Compostos glp-1 acilados
DK1855677T3 (da)	2009-02-09	3,11 B-CIS-dihydrotetrabanezin til behandling af skizofreni og andre psykoser
NO20045554L (no)	2004-12-20	Fremgangsmate for behandling av diabetes
DK1487828T3 (da)	2009-02-02	Morpholinyl-urea-derivater til anvendelse til behandling af inflammatoriske sygdomme
DK1478438T3 (da)	2012-08-27	Fremgangsmåder og sammensætninger til behandling af astma
DK1670482T4 (da)	2022-08-22	Anvendelse af ciclesonid til behandlingen af respiratoriske sygdomme
DK1392355T3 (da)	2007-04-30	Anvendelse af proteasominhibitorer tilbehandling af öjentörhedslidelser
DK1553950T3 (da)	2007-10-15	Terapeutisk behandling
DK1492501T3 (da)	2009-04-06	Fremgangsmåder med anvendelse af lamellare legemer til terapeutiske formål